Prognostic value of DNA ploidy in breast cancer stage I-II

Neoplasma

Volumn 44, Issue 2, 1997, Pages 127-132

  Cufer, T ^a   Lamovec, J ^a   Bracko, M ^a   Lindtner, J ^a   Us Krasovec, M ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Breast cancer; DNA ploidy; prognosis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; DIPLOIDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PROGNOSIS; TUMOR VOLUME;

EID: 0030914025     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BONSING, B.A., BEERMAN, H., KUIPERS-DIJKSHOORN, N., FLEUREN,.G.J., CORNELISSE, C.J.: High levels of DNA index heterogeneity in advanced breast carcinomas. Cancer, 71, 1993, 382-391.
2. BORGIANI, L., COGORNO, P., BUCCARAN, G., GALLO, L., ROVIDA, S., CANEPA, M.: Human breast cancer: Prognostic significance of DNA ploidy compared with c-erbaB2 expression, cathepsin D and silver binding nucleolar organizer regions. Pathologica, 86, 1994, 350-355.
3. CLARK, G.M., DRESSLER, L.G., OWENS, M.A., POUNDS, G., OLDAKER, T., MCGUIRE, W.L.: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N. Engl. J. Med., 320, 1989, 627-633.
4. COLLAN, Y.U., ESKELINEN, M.J., NORDLING, S.A. et al.: Prognostic studies in breast cancer. Acta Oncol., 33, 1994, 873-878.
5. Cox, D.R.: Regression models and life-tables. J. R. Stat. Soc. Bull., 34, 1972, 187-220.
6. DORR, F.A.: Prognostic factors observed in current clinical trials. Cancer, 71, 1993, 2163-2168.
7. DOWLE, C.S., OWAINATI, A., ROBINS, A. et al.: Prognostic significance of the DNA content of human breast cancer. Br. J. Surg., 74, 1987, 133-136.
8. Early Breast Cancer Trialist's Collaborative Group: Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy. Lancet, 339, 1992, 1-15.
9. ELSTON, C.W.: Grading of invasive carcinoma of the breast. In: Diagnostic Histopatology of the Breast. Eds: Page, D.L., Anderson, T.J. Edinbourgh, Churchill Livingstone 1987, 300-311.
10. FALLENIUS, A.G., AUER, G.U., CARSTENSEN, J.M.: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer, 62, 1988, 331-341.
11. FISHER, B., GUNDUZ, N., CONSTANTINO, J. et al.: DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer, 68, 1991, 1465-1475.
12. FRIERSON, H.F. JR.: Ploidy analysis and S-Phase fraction determination by flow-cytometry of invasive adenocarcinomas of the breast. Am. J. Surg. Pathol., 15, 1991, 358-367.
13. HARVEY, J.M., STERRETT, G.F., BERRYMAN, I.L., HOPLEY, J.H.: Nuclear DNA content of human breast carcinoma. A comparison of results obtained by microspectrophotometry and flow cytometry of paraffin embedded tissue. Pathology, 25, 1993, 261-267.
14. HEIDEN, T., WANG, N., TRIBUKAIT, B.: An improved Hedley method for preparation of paraffin-embedded tissue for flow cytometric analysis of ploidy and S-phase. Cytometry, 12, 1991, 614-621.
15. KALLIONEMI, O-P., BLANCO, G., ALAVAIKKO, M. et al.: Tumor DNA ploidy as an independent prognostic factor in breast cancer. Br. J. Cancer, 56, 1987, 637-642.
16. KAPLAN, E.L., MEIER, P.: Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 1958, 457-481.
17. LEWIS, W.E.: Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Cancer, 65, 1990, 2315-2320.
18. MANTEL, N.: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 1966, 163-170.
19. MCGUIRE, W.L.: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res. Treat., 10, 1987, 5-9.
20. Muss, H.B., KUTE, T.E., CASE, L.D. et al.: The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer, 64, 1989, 1894-1900.
21. REYNOLDS, T.: Breast cancer. Prognostic factors - the search goes on. J. Natl. Cancer Inst., 86, 1994, 480-483.
22. SAEZ, R.A., MCGUIRE, W.L., CLARK, G.M.: Prognostic factors in breast cancer. Semin. Surg. Oncol., 5, 1989, 102-110.
23. SHARMA, S., MISHRA, M.C., KAPUR, B.M.L., VERMA, K., NATH, I.: The prognostic significance of ploidy analysis in operable breast cancer. Cancer, 68, 1991, 2612-2616.
24. SIGURDSSON, H., BALDETORP, B., BORG, A. et al.: Indicators of prognosis in node-negative breast cancer. N. Engl. J. Med., 322, 1990, 1045-1053.
25. STAL, O., WINGREN, S., CARSTENSEN, J. et al.: Prognostic value of DNA-ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathologic variables in primary breast cancer. Eur. J. Cancer Clin. Oncol., 25, 1989, 301-309.
26. TOIKKANEN, S., JOENSSU, H., KLEMI, P.: The prognostic significance of nuclear DNA content in invasive breast cancer. A study with long term follow-up. Br. J. Cancer, 60, 1989, 693-700.
27. TRIBUKAIT, B.: Clinical DNA flow cytometry. Med. Oncol. Tumor Pharmacother., 1, 1984, 211-218.
28. US-KRASOVEC, M., BRACKO, M., C̃UFER, T. et al.: Prognostic significance of deoxyribonucleic acid content (DNK) in breast cancer. Zdrav. Vestn., 62, 1993, 531-534. (In Slovenian.)
29. VAN DER LINDEN, J.C., LINDEMAN, J., BAAK, J.P.A., MEIJER, C.J.L.M., HERMAN, C.J.: The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry, 10, 1989, 56-61.
30. WENGER, C.R., BEARDSLEE, S., OWENS, M.A. et al.: DNA-ploidy, S-phase and steroid receptors in more than 127 000 breast cancer patients. Breast Cancer Res. Treat., 28, 1993, 9-20.